DIGOXIN tablet how supplied storage and handling

Revision as of 14:26, 28 February 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Digoxin}} {{CMG}}; {{AE}}:{{AK}} '''''For patient information about Digoxin, click here.''''' ==16 HOW SUPPLIED/STORAGE AND HAN...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Digoxin
DIGOXIN injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
DIGOXIN tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Abdurahman Khalil, M.D. [2]

For patient information about Digoxin, click here.

16 HOW SUPPLIED/STORAGE AND HANDLING

Digoxin Tablets, USP 0.125 mg are Yellow, Round, Scored Tablets, Debossed "W 40" on Scored Side

Bottles of 100 tablets. Bottles of 1000 tablets. Bottles of 5000 tablets.

Digoxin Tablets, USP 0.25 mg are White, Round, Scored Tablets, Debossed "WW 41" on Scored Side

Bottles of 100 tablets. Bottles of 1000 tablets. Bottles of 5000 tablets.

Store in a dry place at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature] and protect from light. Keep out of reach of children.

Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.

References